Evidence map›Paper›PMID 28250971›Full record

ArticleCell death discovery2017

ATF3 reduces migration capacity by regulation of matrix metalloproteinases via NF

Jessica Guenzle, Louisa J Wolf, Nicklas W C Garrelfs, Jonathan M Goeldner, Nadja Osterberg, Cora R Schindler, Joseph E Saavedra, Astrid Weyerbrock

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Nitric oxide regulates adhesiveness, invasiveness, and migration of anoikis-resistant endothelial cells.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jessica GuenzleDepartment of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine, Breisacher Strasse 64, Freiburg D-79106, Germany; University of Freiburg, Faculty of Biology, Schaenzlestrasse 1, Freiburg D-79104, Germany.
Louisa J WolfDepartment of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine , Breisacher Strasse 64, Freiburg D-79106, Germany.
Nicklas W C GarrelfsDepartment of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine , Breisacher Strasse 64, Freiburg D-79106, Germany.
Jonathan M GoeldnerDepartment of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine , Breisacher Strasse 64, Freiburg D-79106, Germany.
Nadja OsterbergDepartment of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine , Breisacher Strasse 64, Freiburg D-79106, Germany.
Cora R SchindlerDepartment of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine , Breisacher Strasse 64, Freiburg D-79106, Germany.
Joseph E SaavedraCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute (NCI) at Frederick , Frederick, MD 21702, USA.
Astrid WeyerbrockDepartment of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine , Breisacher Strasse 64, Freiburg D-79106, Germany.ORCID 0000-0001-9060-4462
University of Freiburg · DEFrederick National Laboratory for Cancer Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma is associated with poor survival and a high recurrence rate in patients due to inevitable uncontrolled infiltrative tumor growth. The elucidation of the molecular mechanisms may offer opportunities to prevent relapses. In this study we investigated the role of the activating transcription factor 3 (ATF3) in migration of GBM cells

Identifiers

PMID28250971
PMCPMC5327503
OpenAlexW2594745042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.